Nano-X Imaging Ltd. (NNOX)
| Market Cap | 62.38M -82.1% |
| Revenue (ttm) | 14.52M +25.7% |
| Net Income | -76.04M |
| EPS | -1.15 |
| Shares Out | 69.60M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,342,082 |
| Open | 0.9628 |
| Previous Close | 0.9738 |
| Day's Range | 0.8746 - 0.9793 |
| 52-Week Range | 0.7343 - 5.4000 |
| Beta | 1.23 |
| Analysts | Buy |
| Price Target | 5.13 (+472.42%) |
| Earnings Date | Aug 11, 2026 |
About NNOX
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to ... [Read more]
Financial Performance
In 2025, Nano-X Imaging's revenue was $13.02 million, an increase of 15.40% compared to the previous year's $11.28 million. Losses were -$75.02 million, 40.2% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for NNOX stock is "Buy." The 12-month stock price target is $5.13, which is an increase of 472.42% from the latest price.
News
Shareholders Sue Nano-X Over Chip Fabrication and Customer Demand Claims
A class action lawsuit was filed against medical imaging company Nano-X Imaging ($NNOX) on June 12, 2026. The federal securities lawsuit alleges that plaintiffs acquired Nano-X stock at artificially i...
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2026 in Nano-X Imaging Ltd. Lawsuit - NNOX
Important Information Regarding Section 20(a) Individual Liability Claims Against Nano-X Imaging's CEO and CFO for Alleged $33.4 Million Q4 Net Loss Important Information Regarding Section 20(a) Indiv...
NNOX Investors Have Rights – If You Lost Money Investing in Nano-X Imaging Ltd. Contact Robbins LLP for Information About Recovering Your Losses
SAN DIEGO, July 09, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nano-X Imaging Ltd. (NASDAQ: ...
REMINDER: Nano-X Imaging Ltd. Investors With Significant Losses Must Act By August 11, 2026
NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ:NNOX) investors of the August 11, 2026 deadline to seek the role of lead...
New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026
New SCCT abstracts from Brigham and Women's Hospital highlight the performance and clinical utility of Nanox.AI's FDA-cleared cardiac AI solution, showing high agreement with expert assessment and its...
Nano-X Imaging downgraded to Neutral from Buy at Alliance Global
Alliance Global downgraded Nano-X Imaging (NNOX) to Neutral from Buy with a price target of $3, down from $5, to reflect lower visibility into the revenue outlook after the company…
NNOX INVESTOR REMINDER: Nano-X Imaging Ltd. Investors Have Until August 11, 2026 To Seek Lead Plaintiff Role
NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ:NNOX) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at inve...
Nano-X Imaging Earnings Call Transcript: Q1 2026
Revenue grew to $4.3M in Q1 2026, driven by teleradiology and Health IT, but cash burn and commercialization delays led to withdrawal of annual revenue guidance. Multiple new partnerships and restructuring efforts are underway, with a focus on operational milestones and cost control.
Nano-X Imaging Earnings release: Q1 2026
Nano-X Imaging released its Q1 2026 earnings on June 25, 2026, summarizing the period's financial results.
Nano-X Imaging reports Q1 EPS (20c), consensus (14c)
Reports Q1 revenue $4.31M, consensus $4.54M. “To date, we are beginning to see revenue and increased scan utilization from the Nanox.ARC,” said Erez Meltzer, CEO and acting chairman. “We’ve altered…
Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates
PETACH TIKVA, Israel, June 25, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class - NNOX
New York, New York--(Newsfile Corp. - June 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nano-X Imaging Ltd. (NASDAQ: NNOX) between March 31, ...
Law Offices of Frank R. Cruz Encourages Nano-X Imaging Ltd.
LOS ANGELES--(BUSINESS WIRE)---- $STOCKS--Law Offices of Frank R. Cruz Encourages Nano-X Imaging Ltd. (NNOX) Shareholders To Inquire About Securities Fraud Class Action.
ROSEN, A LONGSTANDING FIRM, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class - NNOX
New York, New York--(Newsfile Corp. - June 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Nano-X Imaging ...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class - NNOX
New York, New York--(Newsfile Corp. - June 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Nano-X Imaging ...
Law Offices of Howard G. Smith Encourages Nano-X Imaging Ltd.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Nano-X Imaging Ltd. (“Nano-X” or the “Company”)...
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Nano-X Imaging Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class – NNOX
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Nano-X Imaging Ltd. (NASDA...
Nanox to Report First Quarter 2026 Financial Results on June 25, 2026
PETACH TIKVA, Israel, June 11, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will repo...
Nano-X Imaging enters Peruvian market in distribution pact with Top Med
Nanox Imaging announced a distribution agreement with Top Med to deploy the Nanox.ARC system and related services in Peru. Under the agreement, Nanox appointed Top Med as its exclusive distributor…
Exclusive distribution agreement marks Nanox's entry into the Peruvian market
Initial deployment is expected to include six Nanox.ARC systems under a capex model PETACH TIKVA, Israel, June 02, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox”, or the “Company” NASDAQ: NNOX),...
Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
Advances Nanox's ongoing U.S. commercialization and deployment efforts PETACH TIKVA, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Nano X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in...
Nano-X Imaging signs distribution agreement with Radiology Oncology Systems
Nano-X Imaging (NNOX) announced that its U.S.-based subsidiary, Nanox Impact, has signed a distribution agreement with Radiology Oncology Systems to distribute its Nanox.ARC systems across the United ...
Nano-X Imaging price target lowered to $5 from $7 at Alliance Global
Alliance Global lowered the firm’s price target on Nano-X Imaging (NNOX) to $5 from $7 and keeps a Buy rating on the shares. The company reported Q4 results that were…
Nano-X Imaging reports Q1 adjusted EPS (17c), consensus (15c)
Reports Q1 revenue $3.72M, consensus $3.99M.
Nano-X Imaging still sees FY26 revenue $35M, cosnensus $31.58M
Nano-X Imaging (NNOX) said: “The Company’s current revenue base remains at an early stage, and the timing and pace of revenue growth are expected to depend primarily on the timing…